Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Telmisartan 40 mg + Cilnidipine 10 mg + Metoprolol 12.5 mg
Therapeutic Category
Hypertension/ Blood Pressure, Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Alu ALu
Packaging
10x15
Price
₹283/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Telbolife Trio 12.5 Tablet is a fixed-dose combination of three antihypertensive agents designed to provide comprehensive control of high blood pressure.
Telmisartan is an angiotensin II receptor blocker (ARB) that prevents blood vessel constriction, improving blood flow.
Cilnidipine is a dual L/N-type calcium channel blocker that reduces vascular resistance and also modulates sympathetic nerve activity.
Metoprolol is a beta-blocker that slows down the heart rate and reduces cardiac output, offering cardioprotective benefits.
Together, these agents act synergistically to manage blood pressure effectively, reduce cardiovascular risks, and improve long-term outcomes in hypertensive patients, especially those with coexisting cardiac conditions.
Patients may experience dizziness, fatigue, bradycardia, flushing, or swelling of the feet. In rare cases, hypotension, electrolyte imbalance, or gastrointestinal discomfort may occur. Regular monitoring is recommended.
Telbolife Trio 12.5 Tablet is indicated for the treatment of essential hypertension, particularly in patients requiring multi-drug therapy for optimal control. It is also beneficial in patients with cardiac comorbidities such as angina, left ventricular hypertrophy, or mild heart failure, providing vascular protection and enhanced compliance through once-daily dosing.
Use only under medical supervision. Not recommended during pregnancy or breastfeeding. Patients with renal or hepatic impairment, conduction abnormalities, or bronchial asthma should be monitored closely. Avoid abrupt discontinuation.
Store below 25°C in a dry, cool place. Protect from direct light and moisture. Keep out of reach of children.
Composition : Telmisartan (40mg) Tablet
Composition : Telmisartan (40mg) + Amlodipine (5mg) Bilayered
Composition : Telmisartan 20 mg Tablet
Composition : Telmisartan (40mg)
Composition : Telmisartan 80mg Tablet
Composition : Telmisartan (80mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg) Tablet
Composition : Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Composition : Telmisartan 40mg + Amlodipine 5mg + Chlorthalidone 6.25mg
Composition : Telmisartan 40mg + Amlodipine 5mg + Chlorthalidone 12.5mg
Composition : Telmisartan (40mg) + Metoprolol Succinate (25mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Telbolife Trio 12.5 Tablet has strong demand in the cardiac and hypertension management segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on cardiovascular care portfolios.
Medical distributors and agencies can benefit from consistent demand for management of hypertension (high blood pressure), cardiovascular risk management, and heart-related complications associated with uncontrolled BP. Telmisartan 40mg helps lower blood pressure by blocking angiotensin receptors Cilnidipine 10mg helps relax blood vessels and improve circulation Metoprolol 12.5mg helps control heart rate and reduce cardiac workload Together, this triple-combination tablet provides effective blood pressure control and cardiovascular protection, strengthening a reliable cardiac-care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Telbolife Trio 12.5 Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong cardiologist and physician prescriptions, chronic long-term therapy demand, growing market for cardiac medicines, reliable supply chain support, and good margins in cardiovascular products.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.